The National Neurotechnology Initiative (NNTI) Act was introduced into both houses of Congress on March 12, by Rep. Patrick J. Kennedy (D-RI) in the House, and Sen. Patty Murray (D-WA) in the Senate. On her website, Sen. Murray said the legislation was to "help scientists advance their understanding of the human brain and develop new treatments and cures for the millions of Americans who suffer from neurological diseases, conditions and disorders."

The Neurotechnology Industry Organization (NIO) has applauded the legislation. "The huge numbers speak for themselves: There are 100 million Americans suffering from a brain-related illness, with an enormous economic burden that continues to grow as the population ages," said Zack Lynch, Executive Director of the NIO, in a press release. "For a modest investment, Congress has the opportunity to streamline research efforts, accelerate the development of new treatments, promote innovation and job creation by small businesses and have a meaningful impact on the lives of those suffering from devastating diseases and injuries."

According to Sen. Murray's press release on the NNTI, it will increase funding to the National Institutes of Health (NIH); speed up research; coordinate neurological research across federal agencies by creating a blueprint for neuroscience at NIH; and streamline the FDA approval process for important neurological drugs without compromising safety. Sen. Murray also says the Act has the economic benefits of creating jobs in the field of neurotechnology; and through developing better treatments, it will reduce health care costs. The NIO notes that the legislation also creates a research center that will focus on the ethical, legal, and social implications of neurotechnology.

Rep. Kennedy said, "With so many Americans suffering from brain-related illnesses, it is crucial for us as a society to maximize our efforts and continue learning about the many facets of the brain, leading to a healthier life for all Americans."

Congressperson Ileana Ros-Lehtinen (R-FL), a co-sponsor of the bill, said, "This legislation will turn America into a nation where brain injuries and diseases are tackled through innovative technology, state of the art medical equipment and top notch neuroscientists. Together we can make this a reality."

The NIO says the legislation is designed to address four "bottlenecks" that slow the process of developing brain treatments: lack of coordination among agencies with neurotechnology research; lack of coordination within the NIH; insufficient funding in the NIH to develop research and FDA approval process for brain-related drugs, devices, and diagnostics. The funding will provide for the FDA to hire and train neurotech experts.

Adapted in part from a press release by NIO and Sen. Patty Murray.

More Industry Headlines